Syros Pharmaceuticals Inc. (SYRS)

Finanzdaten der Syros Pharmaceuticals Inc.-Aktie (SYRS)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	32.79% 3.762	2.833	2.954	-0.754	3.891
Operating Expenses	4.25% 38.40	36.83	36.17	35.24	43.34
Interest Income/Expense	1.96% 1.303	1.278	1.217	1.126	1.051
Benefits Costs and Expenses	-	-	26.74	-105.51	-
Costs And Expenses	4.25% 38.40	36.83	26.74	45.24	43.34
Operating Income/Loss	1.87% -34.64	-34.00	-33.21	-36.00	-39.45
Income/Loss From Continuing Operations Before Tax	32.79% 3.762	2.833	-23.79	104.76	3.891
Income/Loss From Continuing Operations After Tax	10.71% -40.14	-36.26	-23.79	-4.774	-30.25
Net Income/Loss	10.71% -40.14	-36.26	-23.79	-4.774	-30.25
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.28% 27.99	27.91	27.84	5.0958	9.4171
Diluted Average Shares	0.28% 27.99	27.91	27.84	5.0958	9.4171
Basic Earnings Per Share	10.00% -1.43	-1.30	-0.85	4.44	-3.21
Diluted Earnings Per Share	10.00% -1.43	-1.30	-0.85	4.44	-3.21
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-